Table 4.
Clinical Characteristics of PAH patient and control subjects
| Control | PAH | |
|---|---|---|
| Age | 58.09±10.73 | 55.46±14.19 |
| Sex(Male/Female) | 41/30 | 19/27 |
| Height(cm) | 163.35±9.13 | 165±8.06 |
| Weight(Kg) | 72.12±13.16 | 62.82±11.34 |
| sPAP (mmHg) | NA | 64.8±23.89 |
| NYHA | ||
| I | NA | 1 |
| II | 12 | |
| III | 23 | |
| IV | 10 | |
| BNP (pg/mL) | NA | 321.47 |
| PAH drug therapy | 0 | 2 |
| miR-182-3p | 2.34±0.92 | 0.74±0.56 |
sPAP: systolic pulmonary artery pressure; NYHA: cardiac function classification from New York Heart Association (NYHA); BNP: Brain natriuretic peptide; NA: not available.